This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción 0OPB
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Competidores de McKesson Europe AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €24.20 |
| 52 Week High | €24.30 |
| 52 Week Low | €20.00 |
| Beta | 0.13 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 8.04% |
| 3 Year Change | -6.56% |
| 5 Year Change | -8.33% |
| Change since IPO | -38.09% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 0OPB | GB Healthcare | Mercado GB | |
|---|---|---|---|
| 7D | 0% | 1.3% | -0.7% |
| 1Y | 8.0% | -28.0% | -1.8% |
Rentabilidad vs. Industria: 0OPB underperformed the UK Healthcare industry which returned 17.4% over the past year.
Rentabilidad vs. Mercado: 0OPB exceeded the UK Market which returned 3% over the past year.
Volatilidad de los precios
| 0OPB volatility | |
|---|---|
| 0OPB Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Precio estable de las acciones: 0OPB has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine 0OPB's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1835 | 6,808 | Sebastian Ring | www.mckesson.eu/mck-en |
Resumen de fundamentos de McKesson Europe AG
| Estadísticas fundamentales de 0OPB | |
|---|---|
| Capitalización bursátil | €4.96b |
| Beneficios(TTM) | -€54.30m |
| Ingresos (TTM) | €9.26b |
0.5x
Ratio precio-ventas (PS)-91.3x
Ratio precio-beneficio (PE)¿Está 0OPB sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 0OPB | |
|---|---|
| Ingresos | €9.26b |
| Coste de los ingresos | €8.46b |
| Beneficio bruto | €792.30m |
| Otros gastos | €846.60m |
| Beneficios | -€54.30m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.27 |
| Margen bruto | 8.56% |
| Margen de beneficio neto | -0.59% |
| Ratio deuda/patrimonio | 0.3% |
¿Cómo se ha desempeñado 0OPB a largo plazo?
Ver rendimiento histórico y comparativa